Brandon G. Smaglo

Neoadjuvant Pembrolizumab in Localized Microsatellite Instability High/Deficient Mismatch Repair Solid Tumors

Kaysia Ludford, Won Jin Ho, Jane V. Thomas et al. · Journal of Clinical Oncology · 2023 · 193 citations · Full text

Medicine, Molecular Genetics, Oncology +15

A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies

John F. Deeken, Hongkun Wang, Marion L. Hartley et al. · Cancer Chemotherapy and Pharmacology · 2018 · 95 citations

Medicine, Oncology, Pharmacology +7

Impact of KRAS mutations and co-mutations on clinical outcomes in pancreatic ductal adenocarcinoma

Abdelrahman Yousef, Mahmoud Yousef, Saikat Chowdhury et al. · npj Precision Oncology · 2024 · 82 citations · Full text

Medicine, Molecular Genetics, Oncology +12

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

Benjamin Musher, Eric K. Rowinsky, Brandon G. Smaglo et al. · The Lancet Oncology · 2024 · 65 citations · Full text

Medicine, Immunology, Oncology +16

Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma

Timothy E. Newhook, Timothy J. Vreeland, James F. Griffin et al. · Annals of Surgery · 2021 · 61 citations

Medicine, Oncology, Gastrointestinal Oncology +14